Agente de liberação de monoamina (Portuguese Wikipedia)
Analysis of information sources in references of the Wikipedia article "Agente de liberação de monoamina" in Portuguese language version.
refsWebsite
Global rank
Portuguese rank
3rd place
6th place
5th place
5th place
120th place
157th place
books.google.com
- Brust JC (2004). Neurological Aspects of Substance Abuse. Butterworth-Heinemann. [S.l.: s.n.] pp. 117–. ISBN 978-0-7506-7313-6
- United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly and Anticompetitive Activities (1976). Competitive problems in the drug industry: hearings before Subcommittee on Monopoly and Anticompetitive Activities of the Select Committee on Small Business, United States Senate, Ninetieth Congress, first session. U.S. Government Printing Office. [S.l.: s.n.] pp. 2–
doi.org
dx.doi.org
- Parrott, A. C.; Stuart, M. (setembro de 1997). «Ecstasy (MDMA), amphetamine, and LSD: comparative mood profiles in recreational polydrug users». Human Psychopharmacology: Clinical and Experimental (em inglês). 12: 501–504. CiteSeerX 10.1.1.515.2896
. ISSN 1099-1077. doi:10.1002/(sici)1099-1077(199709/10)12:5<501::aid-hup913>3.3.co;2-m - Morean ME, de Wit H, King AC, Sofuoglu M, Rueger SY, O'Malley SS (maio de 2013). «The drug effects questionnaire: psychometric support across three drug types». Psychopharmacology. 227: 177–92. PMC 3624068. PMID 23271193. doi:10.1007/s00213-012-2954-z
- Nelson RA, Boyd SJ, Ziegelstein RC, Herning R, Cadet JL, Henningfield JE, Schuster CR, Contoreggi C, Gorelick DA (março de 2006). «Effect of rate of administration on subjective and physiological effects of intravenous cocaine in humans». Drug and Alcohol Dependence. 82: 19–24. PMID 16144747. doi:10.1016/j.drugalcdep.2005.08.004
- Berlin I, Warot D, Aymard G, Acquaviva E, Legrand M, Labarthe B, Peyron I, Diquet B, Lechat P (setembro de 2001). «Pharmacodynamics and pharmacokinetics of single nasal (5 mg and 10 mg) and oral (50 mg) doses of ephedrine in healthy subjects». European Journal of Clinical Pharmacology. 57: 447–55. PMID 11699608. doi:10.1007/s002280100317
- Meeusen R, Watson P, Hasegawa H, Roelands B, Piacentini MF (1 de janeiro de 2006). «Central fatigue: the serotonin hypothesis and beyond». Sports Medicine. 36: 881–909. PMID 17004850. doi:10.2165/00007256-200636100-00006
- Roelands B, Meeusen R (março de 2010). «Alterations in central fatigue by pharmacological manipulations of neurotransmitters in normal and high ambient temperature». Sports Medicine. 40: 229–46. PMID 20199121. doi:10.2165/11533670-000000000-00000
nih.gov
ncbi.nlm.nih.gov
- Morean ME, de Wit H, King AC, Sofuoglu M, Rueger SY, O'Malley SS (maio de 2013). «The drug effects questionnaire: psychometric support across three drug types». Psychopharmacology. 227: 177–92. PMC 3624068. PMID 23271193. doi:10.1007/s00213-012-2954-z
- Nelson RA, Boyd SJ, Ziegelstein RC, Herning R, Cadet JL, Henningfield JE, Schuster CR, Contoreggi C, Gorelick DA (março de 2006). «Effect of rate of administration on subjective and physiological effects of intravenous cocaine in humans». Drug and Alcohol Dependence. 82: 19–24. PMID 16144747. doi:10.1016/j.drugalcdep.2005.08.004
- Berlin I, Warot D, Aymard G, Acquaviva E, Legrand M, Labarthe B, Peyron I, Diquet B, Lechat P (setembro de 2001). «Pharmacodynamics and pharmacokinetics of single nasal (5 mg and 10 mg) and oral (50 mg) doses of ephedrine in healthy subjects». European Journal of Clinical Pharmacology. 57: 447–55. PMID 11699608. doi:10.1007/s002280100317
- Powers ME (outubro de 2001). «Ephedra and its application to sport performance: another concern for the athletic trainer?». Journal of Athletic Training. 36: 420–4. PMC 155439. PMID 16558668
- Meeusen R, Watson P, Hasegawa H, Roelands B, Piacentini MF (1 de janeiro de 2006). «Central fatigue: the serotonin hypothesis and beyond». Sports Medicine. 36: 881–909. PMID 17004850. doi:10.2165/00007256-200636100-00006
- Roelands B, Meeusen R (março de 2010). «Alterations in central fatigue by pharmacological manipulations of neurotransmitters in normal and high ambient temperature». Sports Medicine. 40: 229–46. PMID 20199121. doi:10.2165/11533670-000000000-00000
psu.edu
citeseerx.ist.psu.edu
- Parrott, A. C.; Stuart, M. (setembro de 1997). «Ecstasy (MDMA), amphetamine, and LSD: comparative mood profiles in recreational polydrug users». Human Psychopharmacology: Clinical and Experimental (em inglês). 12: 501–504. CiteSeerX 10.1.1.515.2896. ISSN 1099-1077. doi:10.1002/(sici)1099-1077(199709/10)12:5<501::aid-hup913>3.3.co;2-m
researchgate.net
- Roelands B, Meeusen R (março de 2010). «Alterations in central fatigue by pharmacological manipulations of neurotransmitters in normal and high ambient temperature». Sports Medicine. 40: 229–46. PMID 20199121. doi:10.2165/11533670-000000000-00000
worldcat.org
- Parrott, A. C.; Stuart, M. (setembro de 1997). «Ecstasy (MDMA), amphetamine, and LSD: comparative mood profiles in recreational polydrug users». Human Psychopharmacology: Clinical and Experimental (em inglês). 12: 501–504. CiteSeerX 10.1.1.515.2896. ISSN 1099-1077. doi:10.1002/(sici)1099-1077(199709/10)12:5<501::aid-hup913>3.3.co;2-m